rss
Tob Control 2006;15:286-293 doi:10.1136/tc.2005.014555
  • Research paper

Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy

  1. Lawrence C An1,
  2. Barbara A Schillo2,
  3. Annette M Kavanaugh3,
  4. Randi B Lachter2,
  5. Michael G Luxenberg3,
  6. Ann H Wendling2,
  7. Anne M Joseph4
  1. 1University of Minnesota, Department of Internal Medicine, Division of General Medicine, Minneapolis, Minnesota, USA
  2. 2Minnesota Partnership for Action Against Tobacco, Minneapolis, Minnesota, USA
  3. 3Professional Data Analysts, Inc, Minneapolis, Minnesota, USA
  4. 4Minneapolis VA Medical Center, Center for Chronic Disease Outcomes Research, Minneapolis, Minnesota, USA
  1. Correspondence to:
 Lawrence C An
 MD, University of Minnesota, Mayo Building, Mail Code 741, 420 Delaware Street SE, Minneapolis, MN 55455, USA; lcan{at}umn.edu
  • Received 27 September 2005
  • Accepted 20 April 2006

Abstract

Background: Tobacco users receiving behavioural and pharmacological assistance are more likely to quit. Although telephone quitlines provide population access to counselling, few offer pharmacotherapy.

Objective: To assess change in cessation rates and programme impact after the addition of free nicotine replacement therapy (NRT) to statewide quitline services.

Design, setting, participants: An observational study of cohorts of callers to the Minnesota QUITPLANSM Helpline before (n  =  380) and after (n  =  373) the addition of access to free NRT.

Intervention: Mailing of NRT (patch or gum) to callers enrolling in multi-session counselling.

Main outcome measure: Thirty-day abstinence six months after programme registration.

Results: The number of callers increased from 155 (SD 75) to 679 (180) per month pre-NRT to post-NRT (difference 524, 95% confidence interval (CI) 323 to 725). Post-NRT, the proportion of callers enrolling in multi-session counselling (23.4% v 90.1%, difference 66.6%, 95% CI 60.8% to 71.6%) and using pharmacotherapy (46.8% v 86.8%, difference 40.0%, 95% CI 31.3% to 47.9%) increased. Thirty-day abstinence at six months increased from 10.0% pre-NRT to 18.2% post-NRT (difference 8.2%, 95% CI 3.1% to 13.4%). Post-NRT the average number of new ex-smokers per month among registrants increased from 15.5 to 123.6 (difference 108.1, 95% CI 61.1 to 155.0). The cost per quit pre-NRT was $1362 (SD $207). The cost per quit post-NRT was $1934 ($215) suggesting a possible increase in cost per quit (difference $572, 95% CI −$12 to $1157).

Conclusion: The addition of free NRT to a state quitline is followed by increases in participation and abstinence rates resulting in an eightfold increase in programme impact. These findings support the addition of access to pharmacological therapy as part of state quitline services.

Footnotes

  • Competing interests: none declared

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register hereto access the free archive of all BMJ Journals.

Don't forget to sign up for content alertsso you keep up to date with all the articles as they are published.